Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in systemic sclerosis randomized clinical trial
RBR-36qz3pCompleted
- Sponsor
- Sociedade Brasileira de Reumatologia
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in systemic sclerosis (SSc) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Serum cytokine and chemokine levels. Started Aug 2019; status: completed.
02
Drugs
simvastatin
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on RBR-36qz3p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-36qz3p.